David P. Schenkein, Director at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 20,000 shares at $22.15 ($443K) on 2023-03-27, disclosed to the SEC on 2023-03-29.
Scheduled sale ($443k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AGIO | SELL | 2024-02-27 | $4.5M | — | Filing → |
| AGIO | SELL | 2023-04-05 | $748K | — | Filing → |
| AGIO | SELL | 2023-03-15 | $862K | — | Filing → |